• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Endosc . Aerosol protection using modified N95 respirator during upper gastrointestinal endoscopy: a randomized controlled trial

tetano

Editor, Senior Moderator
Clin Endosc


. 2023 Jun 21.
doi: 10.5946/ce.2023.018. Online ahead of print. Aerosol protection using modified N95 respirator during upper gastrointestinal endoscopy: a randomized controlled trial

Chawisa Nampoolsuksan[SUP] 1 [/SUP], Thawatchai Akaraviputh[SUP] 1 [/SUP], Asada Methasate[SUP] 1 [/SUP], Jirawat Swangsri[SUP] 1 [/SUP], Atthaphorn Trakarnsanga[SUP] 1 [/SUP], Chainarong Phalanusitthepha[SUP] 1 [/SUP], Thammawat Parakonthun[SUP] 1 [/SUP], Voraboot Taweerutchana[SUP] 1 [/SUP], Nicha Srisuworanan[SUP] 1 [/SUP], Tharathorn Suwatthanarak[SUP] 1 [/SUP], Thikhamporn Tawantanakorn[SUP] 1 [/SUP], Varut Lohsiriwat[SUP] 1 [/SUP], Vitoon Chinswangwatanakul[SUP] 1 [/SUP]



Affiliations
Abstract

Background/aims: The coronavirus disease 2019 pandemic has affected the worldwide practice of upper gastrointestinal endoscopy. Here we designed a modified N95 respirator with a channel for endoscope insertion and evaluated its efficacy in upper gastrointestinal endoscopy.
Methods: Thirty patients scheduled for upper gastrointestinal endoscopy were randomized into the modified N95 (n=15) or control (n=15) group. The mask was placed on the patient after anesthesia administration and particles were counted every minute before (baseline) and during the procedure by a TSI AeroTrak particle counter (9306-04; TSI Inc.) and categorized by size (0.3, 0.5, 1, 3, 5, and 10 µm). Differences in particle counts between time points were recorded.
Results: During the procedure, the modified N95 group displayed significantly smaller overall particle sizes than the control group (median [interquartile range], 231 [54-385] vs. 579 [213-1,379]×103/m3; p=0.056). However, the intervention group had a significant decrease in 0.3-µm particles (68 [-25-185] vs. 242 [72-588]×103/m3; p=0.045). No adverse events occurred in either group. The device did not cause any inconvenience to the endoscopists or patients.
Conclusions: This modified N95 respirator reduced the number of particles, especially 0.3-µm particles, generated during upper gastrointestinal endoscopy.

Keywords: Aerosols; COVID-19; Endoscopy; Gastroscopy; N95 respirators.

 
Back
Top Bottom